Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David K Cole

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Cellular & Molecular Immunology|October 11, 2005
CD8: adhesion molecule, co-receptor and immuno-modulatorDavid K Cole, George F Gao
Cellular & Molecular Immunology|April 14, 2015
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapyMateusz Legut, David K Cole, Andrew K Sewell
Frontiers in Immunology|July 13, 2013
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not EnoughChristopher J Holland, David K Cole, Andrew Godkin
The FEBS Journal|February 24, 2021
Engineering soluble T-cell receptors for therapyRoss A Robinson, Catriona McMurran, Michelle L McCully, et al.
Molecular Therapy. Oncology|February 6, 2026
Current use of pre-clinical models for evaluation of human adenovirus-based cancer therapeuticsDavid K Cole, Rahul C Khanolkar, James A Davies, et al.
Protein Science : a Publication of the Protein Society|December 31, 2013
The versatility of the αβ T-cell antigen receptorMugdha Bhati, David K Cole, James McCluskey, et al.
Molecular Immunology|December 7, 2010
Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stabilityKim M Miles, John J Miles, Florian Madura, et al.
Journal of Chemical Information and Modeling|January 20, 2022
Reliable <i>In Silico</i> Ranking of Engineered Therapeutic TCR Binding Affinities with MMPB/GBSARory M Crean, Christopher R Pudney, David K Cole, et al.
Discovery Immunology|April 3, 2024
Unconventional modes of peptide-HLA-I presentation change the rules of TCR engagementJade R Hopkins, Bruce J MacLachlan, Stephen Harper, et al.
International Journal of Pharmaceutics|December 10, 2021
Microfluidic-mediated self-assembly of phospholipids for the delivery of biologic moleculesEdward Weaver, Edward O'Connor, David K Cole, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Cellular & Molecular Immunology|October 11, 2005
CD8: adhesion molecule, co-receptor and immuno-modulatorDavid K Cole, George F Gao
Cellular & Molecular Immunology|April 14, 2015
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapyMateusz Legut, David K Cole, Andrew K Sewell
Frontiers in Immunology|July 13, 2013
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not EnoughChristopher J Holland, David K Cole, Andrew Godkin
The FEBS Journal|February 24, 2021
Engineering soluble T-cell receptors for therapyRoss A Robinson, Catriona McMurran, Michelle L McCully, et al.
Molecular Therapy. Oncology|February 6, 2026
Current use of pre-clinical models for evaluation of human adenovirus-based cancer therapeuticsDavid K Cole, Rahul C Khanolkar, James A Davies, et al.
Protein Science : a Publication of the Protein Society|December 31, 2013
The versatility of the αβ T-cell antigen receptorMugdha Bhati, David K Cole, James McCluskey, et al.
Molecular Immunology|December 7, 2010
Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stabilityKim M Miles, John J Miles, Florian Madura, et al.
Journal of Chemical Information and Modeling|January 20, 2022
Reliable <i>In Silico</i> Ranking of Engineered Therapeutic TCR Binding Affinities with MMPB/GBSARory M Crean, Christopher R Pudney, David K Cole, et al.
Discovery Immunology|April 3, 2024
Unconventional modes of peptide-HLA-I presentation change the rules of TCR engagementJade R Hopkins, Bruce J MacLachlan, Stephen Harper, et al.
International Journal of Pharmaceutics|December 10, 2021
Microfluidic-mediated self-assembly of phospholipids for the delivery of biologic moleculesEdward Weaver, Edward O'Connor, David K Cole, et al.
Pageof 11